Domestic Sales Agreement Concluded: Stick-on, Chew-on, Chooseable Smoking Cessation Aid (OTC Drug) 'Nicotinell' Begins Sales from Sato Pharmaceutical
NQ Score
100/100
AI Summary (NQ-processed)
Sato Pharmaceutical Co., Ltd. has entered into a domestic sales agreement with Dr. Reddy's Laboratories Ltd. for the smoking cessation aid "Nicotinell." The product series, available in gum and patch forms, will be launched in Japan on April 1, 2026, to help individuals quit smoking by alleviating withdrawal symptoms.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the launch date for Sato Pharmaceutical's Nicotinell smoking cessation product in Japan?
- A: The Nicotinell product series will be launched in Japan on April 1, 2026.
- Q: Which company has Sato Pharmaceutical partnered with to sell Nicotinell in Japan?
- A: Sato Pharmaceutical has partnered with Dr. Reddy's Laboratories Ltd. for Nicotinell sales.
- Q: What forms of the Nicotinell smoking cessation aid will be available in Japan?
- A: The Nicotinell series will be available in gum and patch forms in Japan.
- Q: What is the brand name of the smoking cessation aid that Sato Pharmaceutical will launch on April 1, 2026?
- A: The brand name of the smoking cessation aid is Nicotinell, launching on April 1, 2026.
- Q: Which pharmaceutical company will distribute Nicotinell products in Japan starting in 2026?
- A: Sato Pharmaceutical Co., Ltd. will distribute Nicotinell products in Japan starting April 1, 2026.